nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—AKR1C3—Doxorubicin—thyroid cancer	0.386	0.717	CbGbCtD
Medroxyprogesterone Acetate—CYP2C8—Sorafenib—thyroid cancer	0.0503	0.0935	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Sorafenib—thyroid cancer	0.0351	0.0652	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Vandetanib—thyroid cancer	0.0338	0.0629	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Sorafenib—thyroid cancer	0.0204	0.0379	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Doxorubicin—thyroid cancer	0.0124	0.023	CbGbCtD
Medroxyprogesterone Acetate—HSD3B2—saliva-secreting gland—thyroid cancer	0.00722	0.184	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—head—thyroid cancer	0.00391	0.0996	CbGeAlD
Medroxyprogesterone Acetate—SHBG—neck—thyroid cancer	0.00294	0.0748	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—lymph node—thyroid cancer	0.00274	0.0698	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—trachea—thyroid cancer	0.00235	0.0599	CbGeAlD
Medroxyprogesterone Acetate—ESR1—neck—thyroid cancer	0.00207	0.0527	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—thyroid gland—thyroid cancer	0.00186	0.0474	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—neck—thyroid cancer	0.00153	0.0389	CbGeAlD
Medroxyprogesterone Acetate—SHBG—thyroid gland—thyroid cancer	0.0014	0.0356	CbGeAlD
Medroxyprogesterone Acetate—PGR—thyroid gland—thyroid cancer	0.00126	0.0321	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—saliva-secreting gland—thyroid cancer	0.00119	0.0303	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—lymph node—thyroid cancer	0.00116	0.0294	CbGeAlD
Medroxyprogesterone Acetate—PGR—head—thyroid cancer	0.00112	0.0285	CbGeAlD
Medroxyprogesterone Acetate—AR—thyroid gland—thyroid cancer	0.001	0.0256	CbGeAlD
Medroxyprogesterone Acetate—ESR1—thyroid gland—thyroid cancer	0.000985	0.0251	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—trachea—thyroid cancer	0.000919	0.0234	CbGeAlD
Medroxyprogesterone Acetate—AR—head—thyroid cancer	0.00089	0.0227	CbGeAlD
Medroxyprogesterone Acetate—ESR1—head—thyroid cancer	0.000874	0.0223	CbGeAlD
Medroxyprogesterone Acetate—PGR—lymph node—thyroid cancer	0.000782	0.0199	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—thyroid gland—thyroid cancer	0.000727	0.0185	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—head—thyroid cancer	0.000645	0.0164	CbGeAlD
Medroxyprogesterone Acetate—AR—lymph node—thyroid cancer	0.000623	0.0159	CbGeAlD
Medroxyprogesterone Acetate—ESR1—lymph node—thyroid cancer	0.000612	0.0156	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—lymph node—thyroid cancer	0.000451	0.0115	CbGeAlD
Medroxyprogesterone Acetate—Increased appetite—Doxorubicin—thyroid cancer	0.000255	0.000888	CcSEcCtD
Medroxyprogesterone Acetate—Migraine—Epirubicin—thyroid cancer	0.000255	0.000888	CcSEcCtD
Medroxyprogesterone Acetate—Affect lability—Epirubicin—thyroid cancer	0.000255	0.000888	CcSEcCtD
Medroxyprogesterone Acetate—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000254	0.000884	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Sorafenib—thyroid cancer	0.000254	0.000884	CcSEcCtD
Medroxyprogesterone Acetate—Face oedema—Epirubicin—thyroid cancer	0.00025	0.000871	CcSEcCtD
Medroxyprogesterone Acetate—Purpura—Doxorubicin—thyroid cancer	0.000249	0.000866	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000248	0.000862	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Sorafenib—thyroid cancer	0.000247	0.00086	CcSEcCtD
Medroxyprogesterone Acetate—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000246	0.000855	CcSEcCtD
Medroxyprogesterone Acetate—Mood swings—Epirubicin—thyroid cancer	0.000245	0.000854	CcSEcCtD
Medroxyprogesterone Acetate—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000245	0.000851	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Sorafenib—thyroid cancer	0.000244	0.000848	CcSEcCtD
Medroxyprogesterone Acetate—Ataxia—Epirubicin—thyroid cancer	0.000244	0.000848	CcSEcCtD
Medroxyprogesterone Acetate—Blood creatinine increased—Epirubicin—thyroid cancer	0.000243	0.000845	CcSEcCtD
Medroxyprogesterone Acetate—Pain in extremity—Doxorubicin—thyroid cancer	0.00024	0.000834	CcSEcCtD
Medroxyprogesterone Acetate—Osteoarthritis—Doxorubicin—thyroid cancer	0.00024	0.000834	CcSEcCtD
Medroxyprogesterone Acetate—Dry skin—Epirubicin—thyroid cancer	0.000237	0.000827	CcSEcCtD
Medroxyprogesterone Acetate—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000237	0.000824	CcSEcCtD
Medroxyprogesterone Acetate—Affect lability—Doxorubicin—thyroid cancer	0.000236	0.000821	CcSEcCtD
Medroxyprogesterone Acetate—Migraine—Doxorubicin—thyroid cancer	0.000236	0.000821	CcSEcCtD
Medroxyprogesterone Acetate—Hypokalaemia—Epirubicin—thyroid cancer	0.000236	0.000821	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Sorafenib—thyroid cancer	0.000236	0.000821	CcSEcCtD
Medroxyprogesterone Acetate—Breast disorder—Epirubicin—thyroid cancer	0.000234	0.000815	CcSEcCtD
Medroxyprogesterone Acetate—Nasopharyngitis—Epirubicin—thyroid cancer	0.000232	0.000806	CcSEcCtD
Medroxyprogesterone Acetate—Face oedema—Doxorubicin—thyroid cancer	0.000231	0.000806	CcSEcCtD
Medroxyprogesterone Acetate—Muscular weakness—Epirubicin—thyroid cancer	0.000228	0.000795	CcSEcCtD
Medroxyprogesterone Acetate—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000228	0.000795	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Sorafenib—thyroid cancer	0.000228	0.000793	CcSEcCtD
Medroxyprogesterone Acetate—Mood swings—Doxorubicin—thyroid cancer	0.000227	0.00079	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal distension—Epirubicin—thyroid cancer	0.000225	0.000785	CcSEcCtD
Medroxyprogesterone Acetate—Ataxia—Doxorubicin—thyroid cancer	0.000225	0.000785	CcSEcCtD
Medroxyprogesterone Acetate—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000224	0.000782	CcSEcCtD
Medroxyprogesterone Acetate—Influenza—Epirubicin—thyroid cancer	0.000224	0.000779	CcSEcCtD
Medroxyprogesterone Acetate—Asthma—Epirubicin—thyroid cancer	0.000224	0.000779	CcSEcCtD
Medroxyprogesterone Acetate—Dysphagia—Epirubicin—thyroid cancer	0.000224	0.000779	CcSEcCtD
Medroxyprogesterone Acetate—Dry skin—Doxorubicin—thyroid cancer	0.00022	0.000765	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Sorafenib—thyroid cancer	0.000219	0.000763	CcSEcCtD
Medroxyprogesterone Acetate—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000219	0.000762	CcSEcCtD
Medroxyprogesterone Acetate—Hypokalaemia—Doxorubicin—thyroid cancer	0.000218	0.000759	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Sorafenib—thyroid cancer	0.000217	0.000756	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Sorafenib—thyroid cancer	0.000217	0.000755	CcSEcCtD
Medroxyprogesterone Acetate—Breast disorder—Doxorubicin—thyroid cancer	0.000217	0.000754	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Sorafenib—thyroid cancer	0.000216	0.000751	CcSEcCtD
Medroxyprogesterone Acetate—Bronchitis—Epirubicin—thyroid cancer	0.000215	0.00075	CcSEcCtD
Medroxyprogesterone Acetate—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000214	0.000746	CcSEcCtD
Medroxyprogesterone Acetate—Muscular weakness—Doxorubicin—thyroid cancer	0.000211	0.000736	CcSEcCtD
Medroxyprogesterone Acetate—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000211	0.000736	CcSEcCtD
Medroxyprogesterone Acetate—Dysuria—Epirubicin—thyroid cancer	0.000209	0.000729	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal distension—Doxorubicin—thyroid cancer	0.000208	0.000726	CcSEcCtD
Medroxyprogesterone Acetate—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000208	0.000724	CcSEcCtD
Medroxyprogesterone Acetate—Asthma—Doxorubicin—thyroid cancer	0.000207	0.000721	CcSEcCtD
Medroxyprogesterone Acetate—Influenza—Doxorubicin—thyroid cancer	0.000207	0.000721	CcSEcCtD
Medroxyprogesterone Acetate—Dysphagia—Doxorubicin—thyroid cancer	0.000207	0.000721	CcSEcCtD
Medroxyprogesterone Acetate—Pollakiuria—Epirubicin—thyroid cancer	0.000207	0.00072	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Sorafenib—thyroid cancer	0.000205	0.000712	CcSEcCtD
Medroxyprogesterone Acetate—Weight increased—Epirubicin—thyroid cancer	0.000204	0.000709	CcSEcCtD
Medroxyprogesterone Acetate—Weight decreased—Epirubicin—thyroid cancer	0.000203	0.000705	CcSEcCtD
Medroxyprogesterone Acetate—Hyperglycaemia—Epirubicin—thyroid cancer	0.000202	0.000703	CcSEcCtD
Medroxyprogesterone Acetate—Drowsiness—Epirubicin—thyroid cancer	0.0002	0.000695	CcSEcCtD
Medroxyprogesterone Acetate—Infestation—Epirubicin—thyroid cancer	0.0002	0.000695	CcSEcCtD
Medroxyprogesterone Acetate—Infestation NOS—Epirubicin—thyroid cancer	0.0002	0.000695	CcSEcCtD
Medroxyprogesterone Acetate—Bronchitis—Doxorubicin—thyroid cancer	0.000199	0.000694	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—CCND1—thyroid cancer	0.000199	0.00147	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000196	0.00145	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—TRIM33—thyroid cancer	0.000196	0.00145	CbGpPWpGaD
Medroxyprogesterone Acetate—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000196	0.000681	CcSEcCtD
Medroxyprogesterone Acetate—Jaundice—Epirubicin—thyroid cancer	0.000195	0.000677	CcSEcCtD
Medroxyprogesterone Acetate—Stomatitis—Epirubicin—thyroid cancer	0.000195	0.000677	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—CCND1—thyroid cancer	0.000194	0.00143	CbGpPWpGaD
Medroxyprogesterone Acetate—Urinary tract infection—Epirubicin—thyroid cancer	0.000194	0.000675	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000194	0.00143	CbGpPWpGaD
Medroxyprogesterone Acetate—Dysuria—Doxorubicin—thyroid cancer	0.000194	0.000674	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—HIF1A—thyroid cancer	0.000193	0.00142	CbGpPWpGaD
Medroxyprogesterone Acetate—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000192	0.00067	CcSEcCtD
Medroxyprogesterone Acetate—Sweating—Epirubicin—thyroid cancer	0.000191	0.000666	CcSEcCtD
Medroxyprogesterone Acetate—Pollakiuria—Doxorubicin—thyroid cancer	0.000191	0.000666	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—CCND1—thyroid cancer	0.000191	0.00141	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—LKB1 signaling events—TP53—thyroid cancer	0.000189	0.00139	CbGpPWpGaD
Medroxyprogesterone Acetate—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000189	0.000657	CcSEcCtD
Medroxyprogesterone Acetate—Weight increased—Doxorubicin—thyroid cancer	0.000188	0.000656	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Epirubicin—thyroid cancer	0.000188	0.000655	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Plasma membrane estrogen receptor signaling—HRAS—thyroid cancer	0.000188	0.00138	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—SLC5A5—thyroid cancer	0.000188	0.00138	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—PTEN—thyroid cancer	0.000187	0.00138	CbGpPWpGaD
Medroxyprogesterone Acetate—Weight decreased—Doxorubicin—thyroid cancer	0.000187	0.000652	CcSEcCtD
Medroxyprogesterone Acetate—Sinusitis—Epirubicin—thyroid cancer	0.000187	0.000652	CcSEcCtD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—MEN1—thyroid cancer	0.000187	0.00138	CbGpPWpGaD
Medroxyprogesterone Acetate—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000187	0.000651	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.000187	0.00138	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—THRB—thyroid cancer	0.000186	0.00137	CbGpPWpGaD
Medroxyprogesterone Acetate—Infestation—Doxorubicin—thyroid cancer	0.000185	0.000643	CcSEcCtD
Medroxyprogesterone Acetate—Drowsiness—Doxorubicin—thyroid cancer	0.000185	0.000643	CcSEcCtD
Medroxyprogesterone Acetate—Infestation NOS—Doxorubicin—thyroid cancer	0.000185	0.000643	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—PTEN—thyroid cancer	0.000185	0.00136	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—CCND1—thyroid cancer	0.000184	0.00136	CbGpPWpGaD
Medroxyprogesterone Acetate—Bradycardia—Epirubicin—thyroid cancer	0.000182	0.000635	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000181	0.00063	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Epirubicin—thyroid cancer	0.00018	0.000627	CcSEcCtD
Medroxyprogesterone Acetate—Jaundice—Doxorubicin—thyroid cancer	0.00018	0.000627	CcSEcCtD
Medroxyprogesterone Acetate—Stomatitis—Doxorubicin—thyroid cancer	0.00018	0.000627	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract infection—Doxorubicin—thyroid cancer	0.000179	0.000625	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Epirubicin—thyroid cancer	0.000179	0.000624	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Epirubicin—thyroid cancer	0.000179	0.000624	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Epirubicin—thyroid cancer	0.000178	0.000619	CcSEcCtD
Medroxyprogesterone Acetate—Sweating—Doxorubicin—thyroid cancer	0.000177	0.000616	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Epirubicin—thyroid cancer	0.000177	0.000616	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Epirubicin—thyroid cancer	0.000176	0.000615	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CALCB—thyroid cancer	0.000176	0.0013	CbGpPWpGaD
Medroxyprogesterone Acetate—Connective tissue disorder—Epirubicin—thyroid cancer	0.000176	0.000613	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000176	0.0013	CbGpPWpGaD
Medroxyprogesterone Acetate—Urethral disorder—Epirubicin—thyroid cancer	0.000176	0.000612	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000175	0.00129	CbGpPWpGaD
Medroxyprogesterone Acetate—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000175	0.000608	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Doxorubicin—thyroid cancer	0.000174	0.000606	CcSEcCtD
Medroxyprogesterone Acetate—Sinusitis—Doxorubicin—thyroid cancer	0.000173	0.000603	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Epirubicin—thyroid cancer	0.000173	0.000601	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—PTEN—thyroid cancer	0.000172	0.00127	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000171	0.00126	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000171	0.00126	CbGpPWpGaD
Medroxyprogesterone Acetate—Erythema multiforme—Epirubicin—thyroid cancer	0.000169	0.00059	CcSEcCtD
Medroxyprogesterone Acetate—Bradycardia—Doxorubicin—thyroid cancer	0.000169	0.000588	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Epirubicin—thyroid cancer	0.000167	0.000583	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TRIM33—thyroid cancer	0.000167	0.00123	CbGpPWpGaD
Medroxyprogesterone Acetate—Tinnitus—Epirubicin—thyroid cancer	0.000167	0.000582	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000167	0.00123	CbGpPWpGaD
Medroxyprogesterone Acetate—Haemoglobin—Doxorubicin—thyroid cancer	0.000167	0.00058	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Epirubicin—thyroid cancer	0.000166	0.000579	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Doxorubicin—thyroid cancer	0.000166	0.000577	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Doxorubicin—thyroid cancer	0.000166	0.000577	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Plasma membrane estrogen receptor signaling—AKT1—thyroid cancer	0.000166	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—Pharyngitis—Doxorubicin—thyroid cancer	0.000165	0.000573	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—RXRA—thyroid cancer	0.000164	0.00121	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—PPARG—thyroid cancer	0.000164	0.00121	CbGpPWpGaD
Medroxyprogesterone Acetate—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000164	0.00057	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Doxorubicin—thyroid cancer	0.000163	0.000569	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000163	0.000567	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Epirubicin—thyroid cancer	0.000163	0.000566	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Doxorubicin—thyroid cancer	0.000163	0.000566	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Epirubicin—thyroid cancer	0.000162	0.000563	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Epirubicin—thyroid cancer	0.000161	0.000562	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Epirubicin—thyroid cancer	0.000161	0.00056	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Doxorubicin—thyroid cancer	0.00016	0.000556	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00016	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000159	0.00117	CbGpPWpGaD
Medroxyprogesterone Acetate—Alopecia—Epirubicin—thyroid cancer	0.000158	0.000551	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—RXRA—thyroid cancer	0.000158	0.00116	CbGpPWpGaD
Medroxyprogesterone Acetate—Mental disorder—Epirubicin—thyroid cancer	0.000157	0.000547	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Doxorubicin—thyroid cancer	0.000157	0.000546	CcSEcCtD
Medroxyprogesterone Acetate—AR—Coregulation of Androgen receptor activity—AKT1—thyroid cancer	0.000157	0.00116	CbGpPWpGaD
Medroxyprogesterone Acetate—Malnutrition—Epirubicin—thyroid cancer	0.000156	0.000543	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Epirubicin—thyroid cancer	0.000156	0.000543	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Doxorubicin—thyroid cancer	0.000155	0.000539	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Doxorubicin—thyroid cancer	0.000155	0.000538	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.000154	0.00114	CbGpPWpGaD
Medroxyprogesterone Acetate—Cardiac disorder—Doxorubicin—thyroid cancer	0.000154	0.000536	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Epirubicin—thyroid cancer	0.000154	0.000535	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000153	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—NRAS—thyroid cancer	0.000153	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—Tension—Epirubicin—thyroid cancer	0.000153	0.000533	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Epirubicin—thyroid cancer	0.000153	0.000532	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Epirubicin—thyroid cancer	0.000151	0.000527	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Gene Expression—TRIM33—thyroid cancer	0.000151	0.00111	CbGpPWpGaD
Medroxyprogesterone Acetate—Back pain—Epirubicin—thyroid cancer	0.000151	0.000525	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Doxorubicin—thyroid cancer	0.00015	0.000524	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Epirubicin—thyroid cancer	0.00015	0.000522	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Doxorubicin—thyroid cancer	0.00015	0.000521	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000149	0.00052	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Doxorubicin—thyroid cancer	0.000149	0.000518	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—TRIM33—thyroid cancer	0.000149	0.0011	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TPR—thyroid cancer	0.000148	0.00109	CbGpPWpGaD
Medroxyprogesterone Acetate—Alopecia—Doxorubicin—thyroid cancer	0.000146	0.00051	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Disease—PRKAR1A—thyroid cancer	0.000145	0.00107	CbGpPWpGaD
Medroxyprogesterone Acetate—Mental disorder—Doxorubicin—thyroid cancer	0.000145	0.000506	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Epirubicin—thyroid cancer	0.000145	0.000504	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Doxorubicin—thyroid cancer	0.000144	0.000502	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Doxorubicin—thyroid cancer	0.000144	0.000502	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Epirubicin—thyroid cancer	0.000144	0.000502	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—MEN1—thyroid cancer	0.000144	0.00106	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.000144	0.00106	CbGpPWpGaD
Medroxyprogesterone Acetate—Agitation—Epirubicin—thyroid cancer	0.000143	0.000499	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Doxorubicin—thyroid cancer	0.000142	0.000495	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—MEN1—thyroid cancer	0.000142	0.00105	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—THRB—thyroid cancer	0.000142	0.00105	CbGpPWpGaD
Medroxyprogesterone Acetate—Tension—Doxorubicin—thyroid cancer	0.000142	0.000493	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TCF7L1—thyroid cancer	0.000141	0.00104	CbGpPWpGaD
Medroxyprogesterone Acetate—Dysgeusia—Doxorubicin—thyroid cancer	0.000141	0.000492	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Epirubicin—thyroid cancer	0.000141	0.00049	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Doxorubicin—thyroid cancer	0.00014	0.000488	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Epirubicin—thyroid cancer	0.00014	0.000488	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Epirubicin—thyroid cancer	0.00014	0.000487	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Doxorubicin—thyroid cancer	0.00014	0.000486	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000139	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MEN1—thyroid cancer	0.000139	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—Muscle spasms—Doxorubicin—thyroid cancer	0.000139	0.000483	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Epirubicin—thyroid cancer	0.000138	0.00048	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Epirubicin—thyroid cancer	0.000137	0.000477	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000136	0.00101	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000136	0.001	CbGpPWpGaD
Medroxyprogesterone Acetate—Convulsion—Epirubicin—thyroid cancer	0.000135	0.000471	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000134	0.000466	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Doxorubicin—thyroid cancer	0.000133	0.000464	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Epirubicin—thyroid cancer	0.000133	0.000462	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Epirubicin—thyroid cancer	0.000133	0.000462	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Epirubicin—thyroid cancer	0.000133	0.000462	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Doxorubicin—thyroid cancer	0.000133	0.000462	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Epirubicin—thyroid cancer	0.000132	0.000461	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—KRAS—thyroid cancer	0.000132	0.000973	CbGpPWpGaD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000132	0.000459	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000132	0.000971	CbGpPWpGaD
Medroxyprogesterone Acetate—Discomfort—Epirubicin—thyroid cancer	0.000131	0.000457	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Doxorubicin—thyroid cancer	0.00013	0.000453	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Epirubicin—thyroid cancer	0.00013	0.000452	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Doxorubicin—thyroid cancer	0.00013	0.000451	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Doxorubicin—thyroid cancer	0.000129	0.000451	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000129	0.000954	CbGpPWpGaD
Medroxyprogesterone Acetate—Confusional state—Epirubicin—thyroid cancer	0.000128	0.000447	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—RXRA—thyroid cancer	0.000128	0.000945	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TP53—thyroid cancer	0.000128	0.000944	CbGpPWpGaD
Medroxyprogesterone Acetate—Palpitations—Doxorubicin—thyroid cancer	0.000128	0.000444	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Epirubicin—thyroid cancer	0.000127	0.000443	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Epirubicin—thyroid cancer	0.000127	0.000443	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Doxorubicin—thyroid cancer	0.000127	0.000442	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Epirubicin—thyroid cancer	0.000126	0.00044	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TP53—thyroid cancer	0.000126	0.00093	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—TPR—thyroid cancer	0.000126	0.000927	CbGpPWpGaD
Medroxyprogesterone Acetate—Shock—Epirubicin—thyroid cancer	0.000125	0.000436	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Doxorubicin—thyroid cancer	0.000125	0.000435	CcSEcCtD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—RXRA—thyroid cancer	0.000125	0.000922	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000125	0.000922	CbGpPWpGaD
Medroxyprogesterone Acetate—Nervous system disorder—Epirubicin—thyroid cancer	0.000125	0.000435	CcSEcCtD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000125	0.000921	CbGpPWpGaD
Medroxyprogesterone Acetate—Thrombocytopenia—Epirubicin—thyroid cancer	0.000125	0.000434	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Epirubicin—thyroid cancer	0.000124	0.000433	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—TPR—thyroid cancer	0.000124	0.000913	CbGpPWpGaD
Medroxyprogesterone Acetate—Skin disorder—Epirubicin—thyroid cancer	0.000124	0.000431	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Epirubicin—thyroid cancer	0.000123	0.000428	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Doxorubicin—thyroid cancer	0.000123	0.000428	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Doxorubicin—thyroid cancer	0.000123	0.000428	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Doxorubicin—thyroid cancer	0.000123	0.000428	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Doxorubicin—thyroid cancer	0.000122	0.000426	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000122	0.000425	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PRKAR1A—thyroid cancer	0.000122	0.000899	CbGpPWpGaD
Medroxyprogesterone Acetate—Discomfort—Doxorubicin—thyroid cancer	0.000121	0.000423	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Epirubicin—thyroid cancer	0.000121	0.000422	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Doxorubicin—thyroid cancer	0.00012	0.000418	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Epirubicin—thyroid cancer	0.000119	0.000414	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Doxorubicin—thyroid cancer	0.000119	0.000414	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Gene Expression—MEN1—thyroid cancer	0.000118	0.000871	CbGpPWpGaD
Medroxyprogesterone Acetate—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000118	0.00041	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Doxorubicin—thyroid cancer	0.000118	0.00041	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Doxorubicin—thyroid cancer	0.000117	0.000407	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000116	0.000404	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Doxorubicin—thyroid cancer	0.000116	0.000403	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—HRAS—thyroid cancer	0.000116	0.000854	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—AKT1—thyroid cancer	0.000116	0.000854	CbGpPWpGaD
Medroxyprogesterone Acetate—Nervous system disorder—Doxorubicin—thyroid cancer	0.000115	0.000402	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000115	0.000402	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Epirubicin—thyroid cancer	0.000115	0.000401	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Doxorubicin—thyroid cancer	0.000115	0.0004	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Doxorubicin—thyroid cancer	0.000114	0.000398	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Epirubicin—thyroid cancer	0.000114	0.000398	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000114	0.000396	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Epirubicin—thyroid cancer	0.000113	0.000395	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Epirubicin—thyroid cancer	0.000113	0.000394	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000113	0.000833	CbGpPWpGaD
Medroxyprogesterone Acetate—Anorexia—Doxorubicin—thyroid cancer	0.000112	0.000391	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—HRAS—thyroid cancer	0.000112	0.000827	CbGpPWpGaD
Medroxyprogesterone Acetate—Dyspepsia—Epirubicin—thyroid cancer	0.000112	0.00039	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TCF7L1—thyroid cancer	0.000112	0.000823	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—thyroid cancer	0.000111	0.000819	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000111	0.000817	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CALCA—thyroid cancer	0.000111	0.000817	CbGpPWpGaD
Medroxyprogesterone Acetate—Decreased appetite—Epirubicin—thyroid cancer	0.000111	0.000385	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—AKT1—thyroid cancer	0.000111	0.000816	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.00011	0.000815	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypotension—Doxorubicin—thyroid cancer	0.00011	0.000383	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00011	0.000383	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Epirubicin—thyroid cancer	0.00011	0.000382	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Gene Expression—THRB—thyroid cancer	0.000109	0.000805	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000109	0.000804	CbGpPWpGaD
Medroxyprogesterone Acetate—Constipation—Epirubicin—thyroid cancer	0.000109	0.000379	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—THRB—thyroid cancer	0.000107	0.000793	CbGpPWpGaD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000107	0.000374	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Doxorubicin—thyroid cancer	0.000107	0.000371	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Doxorubicin—thyroid cancer	0.000106	0.000368	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000105	0.000775	CbGpPWpGaD
Medroxyprogesterone Acetate—Dyspnoea—Doxorubicin—thyroid cancer	0.000105	0.000366	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Epirubicin—thyroid cancer	0.000105	0.000365	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Doxorubicin—thyroid cancer	0.000105	0.000365	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—RXRA—thyroid cancer	0.000104	0.000769	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000104	0.000362	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Doxorubicin—thyroid cancer	0.000104	0.000361	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—PPARG—thyroid cancer	0.000104	0.000764	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CALCB—thyroid cancer	0.000104	0.000764	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TSHR—thyroid cancer	0.000104	0.000764	CbGpPWpGaD
Medroxyprogesterone Acetate—Decreased appetite—Doxorubicin—thyroid cancer	0.000102	0.000356	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Leptin signaling pathway—AKT1—thyroid cancer	0.000102	0.000754	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PRKAR1A—thyroid cancer	0.000102	0.000751	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000102	0.000354	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Doxorubicin—thyroid cancer	0.000102	0.000354	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000101	0.000748	CbGpPWpGaD
Medroxyprogesterone Acetate—Urticaria—Epirubicin—thyroid cancer	0.000101	0.000352	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000101	0.000745	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—PTEN—thyroid cancer	0.000101	0.000744	CbGpPWpGaD
Medroxyprogesterone Acetate—Constipation—Doxorubicin—thyroid cancer	0.000101	0.000351	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Epirubicin—thyroid cancer	0.000101	0.00035	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Epirubicin—thyroid cancer	0.000101	0.00035	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Disease—CDK1—thyroid cancer	0.0001	0.000739	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PPARG—thyroid cancer	9.96e-05	0.000734	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—AKT1—thyroid cancer	9.9e-05	0.00073	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TRIM33—thyroid cancer	9.82e-05	0.000724	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MEN1—thyroid cancer	9.73e-05	0.000718	CbGpPWpGaD
Medroxyprogesterone Acetate—Feeling abnormal—Doxorubicin—thyroid cancer	9.71e-05	0.000338	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—RXRA—thyroid cancer	9.63e-05	0.00071	CbGpPWpGaD
Medroxyprogesterone Acetate—Gastrointestinal pain—Doxorubicin—thyroid cancer	9.63e-05	0.000335	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	9.63e-05	0.00071	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	9.61e-05	0.000709	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—TPR—thyroid cancer	9.57e-05	0.000706	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—RXRA—thyroid cancer	9.49e-05	0.0007	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	9.47e-05	0.000698	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MINPP1—thyroid cancer	9.41e-05	0.000694	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Epirubicin—thyroid cancer	9.38e-05	0.000327	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	9.38e-05	0.000692	CbGpPWpGaD
Medroxyprogesterone Acetate—Urticaria—Doxorubicin—thyroid cancer	9.36e-05	0.000326	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Doxorubicin—thyroid cancer	9.31e-05	0.000324	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Doxorubicin—thyroid cancer	9.31e-05	0.000324	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—SLC5A5—thyroid cancer	9.27e-05	0.000684	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Epirubicin—thyroid cancer	9.13e-05	0.000318	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Epirubicin—thyroid cancer	9.01e-05	0.000314	CcSEcCtD
Medroxyprogesterone Acetate—AR—Gene Expression—MEN1—thyroid cancer	9e-05	0.000664	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—NRAS—thyroid cancer	8.99e-05	0.000664	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TP53—thyroid cancer	8.98e-05	0.000662	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PTCH1—thyroid cancer	8.8e-05	0.000649	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Epirubicin—thyroid cancer	8.71e-05	0.000303	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	8.7e-05	0.000642	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.69e-05	0.000641	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Doxorubicin—thyroid cancer	8.68e-05	0.000302	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Doxorubicin—thyroid cancer	8.45e-05	0.000294	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Epirubicin—thyroid cancer	8.42e-05	0.000293	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	8.4e-05	0.00062	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	8.37e-05	0.000618	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Doxorubicin—thyroid cancer	8.33e-05	0.00029	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TSHR—thyroid cancer	8.17e-05	0.000603	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Epirubicin—thyroid cancer	8.09e-05	0.000282	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Doxorubicin—thyroid cancer	8.06e-05	0.000281	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SST—thyroid cancer	8.05e-05	0.000594	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—NRG1—thyroid cancer	8.04e-05	0.000593	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PRKAR1A—thyroid cancer	8.04e-05	0.000593	CbGpPWpGaD
Medroxyprogesterone Acetate—Rash—Epirubicin—thyroid cancer	8.03e-05	0.000279	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Epirubicin—thyroid cancer	8.02e-05	0.000279	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NDUFA13—thyroid cancer	8e-05	0.00059	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Epirubicin—thyroid cancer	7.97e-05	0.000278	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Gene Expression—RXRA—thyroid cancer	7.9e-05	0.000583	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—PPARG—thyroid cancer	7.89e-05	0.000582	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PTGS2—thyroid cancer	7.83e-05	0.000578	CbGpPWpGaD
Medroxyprogesterone Acetate—Dizziness—Doxorubicin—thyroid cancer	7.79e-05	0.000271	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—RXRA—thyroid cancer	7.79e-05	0.000575	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	7.78e-05	0.000574	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CALCA—thyroid cancer	7.75e-05	0.000572	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—KRAS—thyroid cancer	7.74e-05	0.000571	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MEN1—thyroid cancer	7.68e-05	0.000566	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MINPP1—thyroid cancer	7.66e-05	0.000565	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	7.58e-05	0.000559	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.57e-05	0.000559	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Epirubicin—thyroid cancer	7.56e-05	0.000263	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CHST14—thyroid cancer	7.52e-05	0.000555	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Doxorubicin—thyroid cancer	7.49e-05	0.000261	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	7.44e-05	0.000549	CbGpPWpGaD
Medroxyprogesterone Acetate—Rash—Doxorubicin—thyroid cancer	7.43e-05	0.000259	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Doxorubicin—thyroid cancer	7.42e-05	0.000258	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Doxorubicin—thyroid cancer	7.38e-05	0.000257	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Gene Expression—TPR—thyroid cancer	7.37e-05	0.000544	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—TPR—thyroid cancer	7.26e-05	0.000536	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TERT—thyroid cancer	7.22e-05	0.000533	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CDK1—thyroid cancer	7.02e-05	0.000518	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Doxorubicin—thyroid cancer	7e-05	0.000244	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PTCH1—thyroid cancer	6.94e-05	0.000512	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—MEN1—thyroid cancer	6.93e-05	0.000511	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	6.92e-05	0.00051	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HIF1A—thyroid cancer	6.91e-05	0.000509	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—RXRA—thyroid cancer	6.87e-05	0.000507	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PTEN—thyroid cancer	6.83e-05	0.000504	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—MEN1—thyroid cancer	6.83e-05	0.000504	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—HRAS—thyroid cancer	6.58e-05	0.000485	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TCF7L1—thyroid cancer	6.55e-05	0.000483	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NDUFA13—thyroid cancer	6.51e-05	0.00048	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	6.45e-05	0.000476	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SST—thyroid cancer	6.35e-05	0.000469	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	6.28e-05	0.000463	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CHST14—thyroid cancer	6.12e-05	0.000452	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CALCA—thyroid cancer	6.11e-05	0.000451	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—PPARG—thyroid cancer	6.08e-05	0.000449	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—HPGD—thyroid cancer	6.06e-05	0.000447	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—RXRA—thyroid cancer	6.02e-05	0.000444	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—PPARG—thyroid cancer	5.99e-05	0.000442	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	5.84e-05	0.000431	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—AKT1—thyroid cancer	5.81e-05	0.000429	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	5.73e-05	0.000423	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—BRAF—thyroid cancer	5.72e-05	0.000422	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NRG1—thyroid cancer	5.63e-05	0.000415	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CDK1—thyroid cancer	5.53e-05	0.000408	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TERT—thyroid cancer	5.06e-05	0.000373	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MINPP1—thyroid cancer	5.05e-05	0.000372	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—PPARG—thyroid cancer	4.99e-05	0.000368	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—HPGD—thyroid cancer	4.93e-05	0.000364	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PPARG—thyroid cancer	4.92e-05	0.000363	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.92e-05	0.000363	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	4.84e-05	0.000357	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HIF1A—thyroid cancer	4.84e-05	0.000357	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TSHR—thyroid cancer	4.79e-05	0.000354	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PRKAR1A—thyroid cancer	4.72e-05	0.000348	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—RXRA—thyroid cancer	4.64e-05	0.000342	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTGS2—thyroid cancer	4.62e-05	0.000341	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—RXRA—thyroid cancer	4.57e-05	0.000337	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MEN1—thyroid cancer	4.51e-05	0.000332	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NRG1—thyroid cancer	4.44e-05	0.000328	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NDUFA13—thyroid cancer	4.29e-05	0.000317	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTCH1—thyroid cancer	4.08e-05	0.000301	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CHST14—thyroid cancer	4.04e-05	0.000298	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTEN—thyroid cancer	4.03e-05	0.000297	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—BRAF—thyroid cancer	4e-05	0.000295	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4e-05	0.000295	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TERT—thyroid cancer	3.99e-05	0.000294	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—AKT1—thyroid cancer	3.94e-05	0.00029	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTGS2—thyroid cancer	3.87e-05	0.000285	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HIF1A—thyroid cancer	3.81e-05	0.000281	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—PPARG—thyroid cancer	3.8e-05	0.00028	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SST—thyroid cancer	3.73e-05	0.000275	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—NRAS—thyroid cancer	3.59e-05	0.000265	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CALCA—thyroid cancer	3.59e-05	0.000265	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TPR—thyroid cancer	3.48e-05	0.000257	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	3.43e-05	0.000253	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTEN—thyroid cancer	3.37e-05	0.000249	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HPGD—thyroid cancer	3.25e-05	0.00024	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CDK1—thyroid cancer	3.25e-05	0.00024	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—BRAF—thyroid cancer	3.16e-05	0.000233	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.1e-05	0.000229	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—KRAS—thyroid cancer	3.09e-05	0.000228	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PPARG—thyroid cancer	2.93e-05	0.000216	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCND1—thyroid cancer	2.92e-05	0.000216	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PPARG—thyroid cancer	2.88e-05	0.000213	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TPR—thyroid cancer	2.83e-05	0.000209	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PTEN—thyroid cancer	2.82e-05	0.000208	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	2.79e-05	0.000206	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—HRAS—thyroid cancer	2.63e-05	0.000194	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NRG1—thyroid cancer	2.61e-05	0.000192	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—SLC5A5—thyroid cancer	2.61e-05	0.000192	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.53e-05	0.000186	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NRAS—thyroid cancer	2.52e-05	0.000186	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.44e-05	0.00018	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TERT—thyroid cancer	2.34e-05	0.000173	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—AKT1—thyroid cancer	2.32e-05	0.000171	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCND1—thyroid cancer	2.31e-05	0.00017	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HIF1A—thyroid cancer	2.24e-05	0.000165	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PTEN—thyroid cancer	2.23e-05	0.000164	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—RXRA—thyroid cancer	2.19e-05	0.000162	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—KRAS—thyroid cancer	2.17e-05	0.00016	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.13e-05	0.000157	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—SLC5A5—thyroid cancer	2.12e-05	0.000156	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.99e-05	0.000147	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NRAS—thyroid cancer	1.99e-05	0.000146	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—AKT1—thyroid cancer	1.97e-05	0.000145	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—AKT1—thyroid cancer	1.94e-05	0.000143	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TP53—thyroid cancer	1.93e-05	0.000142	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TPR—thyroid cancer	1.87e-05	0.000138	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—BRAF—thyroid cancer	1.85e-05	0.000137	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HRAS—thyroid cancer	1.84e-05	0.000136	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.84e-05	0.000136	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—RXRA—thyroid cancer	1.78e-05	0.000131	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.73e-05	0.000128	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—KRAS—thyroid cancer	1.71e-05	0.000126	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AKT1—thyroid cancer	1.63e-05	0.00012	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TP53—thyroid cancer	1.52e-05	0.000112	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—AKT1—thyroid cancer	1.5e-05	0.000111	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HRAS—thyroid cancer	1.45e-05	0.000107	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.4e-05	0.000103	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPARG—thyroid cancer	1.38e-05	0.000102	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCND1—thyroid cancer	1.35e-05	9.98e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTEN—thyroid cancer	1.31e-05	9.63e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AKT1—thyroid cancer	1.28e-05	9.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—RXRA—thyroid cancer	1.18e-05	8.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NRAS—thyroid cancer	1.17e-05	8.59e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—AKT1—thyroid cancer	1.16e-05	8.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—AKT1—thyroid cancer	1.14e-05	8.41e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPARG—thyroid cancer	1.13e-05	8.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—thyroid cancer	1.09e-05	8.02e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KRAS—thyroid cancer	1e-05	7.4e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTEN—thyroid cancer	9.48e-06	7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TP53—thyroid cancer	8.91e-06	6.57e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—thyroid cancer	8.85e-06	6.53e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HRAS—thyroid cancer	8.52e-06	6.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTEN—thyroid cancer	7.72e-06	5.69e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AKT1—thyroid cancer	7.53e-06	5.55e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPARG—thyroid cancer	7.42e-06	5.47e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.84e-06	4.31e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AKT1—thyroid cancer	5.47e-06	4.03e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTEN—thyroid cancer	5.09e-06	3.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AKT1—thyroid cancer	4.45e-06	3.28e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AKT1—thyroid cancer	2.93e-06	2.16e-05	CbGpPWpGaD
